On October 30, 2025, iSpecimen Inc. held a special stockholder meeting where key proposals were approved, including a reverse stock split (1:10 to 1:100), an increase in authorized shares from 250M to 1B, and entry into an equity line of credit arrangement, among others. A total of 1,437,502 shares were voted, representing 36% of outstanding shares.